AVITA Medical, Inc. (RCEL) Free Cash Flow (2019 - 2025)

AVITA Medical (RCEL) has reported Free Cash Flow for 7 consecutive years, with -$4.8 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Free Cash Flow rose 50.6% year-over-year to -$4.8 million; the trailing twelve-month figure through Dec 2025 stood at -$32.2 million (up 44.54% YoY), and the FY2025 full-year result was -$32.2 million, up 44.54% from the prior year.
• Free Cash Flow improved to -$4.8 million in Q4 2025 per RCEL's latest filing, from -$6.2 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $7.5 million in Q4 2022 and bottomed at -$22.0 million in Q1 2024.
• Historically, Free Cash Flow has averaged -$9.9 million across 5 years, with a median of -$9.7 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Free Cash Flow sank 248.17% in 2023, then surged 54.34% in 2025.
• Over 5 years, Free Cash Flow stood at -$13.9 million in 2021, then jumped by 154.21% to $7.5 million in 2022, then tumbled by 248.17% to -$11.2 million in 2023, then gained by 13.49% to -$9.7 million in 2024, then jumped by 50.6% to -$4.8 million in 2025.
• According to Business Quant data, Free Cash Flow over the past three periods registered -$4.8 million, -$6.2 million, and -$11.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.